Literature DB >> 25842263

Notch1 ligand signaling pathway activated in cervical cancer: poor prognosis with high-level JAG1/Notch1.

Nasser Ghaly Yousif1, Alaa Muhammad Sadiq, Maitham G Yousif, Rihab H Al-Mudhafar, Jinan J Al-Baghdadi, Najah Hadi.   

Abstract

OBJECTIVE: Notch signalings are regulated multiple cellular processes during cancer progression. We aimed to investigate the significance and prognostic value of expression of Notch1 and JAG1 in cervical cancer to determine whether they could serve as prognostic predictors. METHODS/MATERIALS: The expression of Notch1/JAGD1 was investigated by real-time PCR, western blot assay and its association with overall survival of patients was analyzed by statistical analysis.
RESULTS: Notch1 and JAGD1 expression level were significantly elevated in cervical cancer in comparison to normal specimens and other types of Notch receptors and ligands. It is also proved that Notch1 and JAGD1 expression were to be associated with cervical cancer invasion, lymph node metastasis, and FIGO system. In addition, survival analysis proved that elevated Notch1 and JAGD1 expression were associated with poor overall survival of patients (P = 0.01, P = 0.02 log-rank test), respectively.
CONCLUSIONS: The present data proved the over-expression of Notch1/JAGD1 and its association with tumor progression in human cervical cancer, which might be a potential valuable biomarker for cervical cancer and further studies need.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25842263     DOI: 10.1007/s00404-015-3694-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Takahito Fukusumi; Theresa W Guo; Akihiro Sakai; Mizuo Ando; Shuling Ren; Sunny Haft; Chao Liu; Panomwat Amornphimoltham; J Silvio Gutkind; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2017-11-16       Impact factor: 12.531

2.  Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues.

Authors:  Rajeswari Narayanappa; Pritilata Rout; Madhuri G S Aithal; Ashis Kumar Chand
Journal:  Tumour Biol       Date:  2015-12-11

3.  Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.

Authors:  Lichun Sun; Mingqiu Liu; Guang-Chun Sun; Xu Yang; Qingqing Qian; Shuyu Feng; L Vienna Mackey; David H Coy
Journal:  J Cancer       Date:  2016-06-30       Impact factor: 4.207

4.  Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans.

Authors:  L Che; B Fan; M G Pilo; Z Xu; Y Liu; A Cigliano; A Cossu; G Palmieri; R M Pascale; A Porcu; G Vidili; M Serra; F Dombrowski; S Ribback; D F Calvisi; X Chen
Journal:  Oncogenesis       Date:  2016-12-05       Impact factor: 7.485

5. 

Authors:  Nadežda Lachej; Daiva Dabkevičienė; Aušra Sasnauskienė; Rūta Marija Trimonytė; Daiva Kanopienė; Birutė Kazbarienė; Janina Didžiapetrienė
Journal:  Acta Med Litu       Date:  2017

6.  Jagged-1 induced molecular alterations in HPV associated invasive squamous cell and adenocarcinoma of the human uterine cervix.

Authors:  Richa Tripathi; Gayatri Rath; Showket Hussain; Poonam Jawanjal; Kapil Bandil; Vishwas Sharma; Mausumi Bharadwaj; Ravi Mehrotra
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

7.  Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.

Authors:  Zhi-Yan Liu; Tao Wu; Qing Li; Min-Cong Wang; Li Jing; Zhi-Ping Ruan; Yu Yao; Ke-Jun Nan; Hui Guo
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy.

Authors:  Elenaé Vázquez-Ulloa; Ana Clara Ramos-Cruz; Diddier Prada; Alejandro Avilés-Salas; Alma Delia Chávez-Blanco; Luis A Herrera; Marcela Lizano; Adriana Contreras-Paredes
Journal:  Oncotarget       Date:  2018-04-10

9.  Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.

Authors:  Lu Wang; Guo Dai; Jian Yang; Wanrong Wu; Wei Zhang
Journal:  Med Sci Monit       Date:  2018-06-14

10.  SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway.

Authors:  Rong Hu; Ming-Qing Wang; Wen-Bo Niu; Yan-Jing Wang; Yang-Yang Liu; Ling-Yu Liu; Ming Wang; Juan Zhong; Hai-Yan You; Xiao-Hui Wu; Ning Deng; Lu Lu; Lian-Bo Wei
Journal:  Cancer Cell Int       Date:  2018-11-14       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.